Otsuka Holdings Co., Ltd. OTSKF OTC · Healthcare · Japan
$73.16 +0.00% +$0.00
Summary
77 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 41% a year over the last 3 years.
- Out of every 100 JPY of revenue, 14 JPY is left as net profit.
- It holds more cash than debt: ¥472.5B against ¥191.5B.
- The share price is below the Bulios Fair Price.
What to watch
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 15.8 JPY for 1 JPY of yearly profit. Over the last five years it was 17.2 JPY on average.
Valuation in detailIs it growing?
Yes, fastRevenue (JPY)
Diluted EPS (JPY)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 12% a year. For the next fiscal year analysts expect revenue to grow by 10%. Earnings per share grew by 41% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 JPY of revenue goes
- Cost of sales 28 JPY
- Research and development 14 JPY
- Sales and administration 41 JPY
- Taxes and other 3.4 JPY
- Net profit 14 JPY
Net profit, industry median (Drug Manufacturers - General) 14 JPY
Out of every 100 JPY of revenue, 14 JPY is left as net profit.
Profitability in detailIs it financially healthy?
YesIt could repay all its debt from a single year of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 1.24%
- Paid out of profit
- 20%
- Raised in a row
- 2 years
You receive $0.90 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.